NCT05627752 2024-02-28
Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage
Zhongnan Hospital
Phase 2/3 Unknown
Clinical Trials
12 trialsNCT05841992 2023-05-03
Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients
Peking Union Medical College Hospital
Phase 2/3 Unknown
NCT03879122 2022-10-26
A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer
Spanish Oncology Genito-Urinary Group
Phase 2/3 Unknown
NCT04796467 2022-08-09
68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients
Peking Union Medical College Hospital
Phase 2/3 Unknown
NCT02759783 2019-08-21
CORE
Royal Marsden NHS Foundation Trust
Phase 2/3 Unknown
NCT03852654 2019-02-25
18F-DCFPyL PET-CT Scan and Prostate Cancer
VA Greater Los Angeles Healthcare System
Phase 2/3 Unknown
NCT03344822 2017-11-17
TePSMAG-68
Central Hospital, Nancy, France
Phase 2/3 Unknown
NCT02016040 2017-04-19
Focal Therapy Using HIFU for Localised Prostate Cancer
Jewish General Hospital
Phase 2/3 Unknown
NCT01787630 2016-11-04
NoHarm
Umeå University
Phase 2/3 Unknown
NCT02265159 2016-10-27
Intervention Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound for the Treatment of Prostate Cancer
University of Zurich
Phase 2/3 Unknown
NCT00295802 2014-02-07
Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer
EDAP TMS S.A.
Phase 2/3 Unknown
NCT00043576 2009-03-12
ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
Novacea
Phase 2/3 Unknown